Off-Label Compliance 2011

This conference will provide you with current tools for overcoming the challenges associated with drug and device promotion and unintended use. Attendees will learn how to minimize risk in off-label discussions and ensure that doctors are properly educated on products. In addition, attendees will learn how to strike a balance between increased sales revenue, increased development time and expanding indications; which is a lengthy and costly process.

You will hear about successful compliance plans, effective business practices, and winning litigation tactics from leading in-house counsel, compliance and regulatory officers, and expert attorneys who represent the pharmaceutical and device industries. Finally, attendees will walk away with a better understanding of how to comply with the FDA and prevent off label usage lawsuits that are very common in the pharma industry.